Condition
Indolent B-Cell Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Indolent B-Cell Non-Hodgkin Lymphoma clinical trials that are recruiting, at sites in 7 countries (most in United States (3), Taiwan (1), Brazil (1)). By phase: Phase 2 (2), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Indolent B-Cell Non-Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310 | Phase 1 | Denver, Colorado and 4 other locations | Recruiting | Aug 9, 2024 |
| Using Ga-68-CXCR4 PET/CT to improve detection of indolent B-cell lymphoma | Phase 2 | Taipei, Beitou | Recruiting | Jun 14, 2024 |
| Reduced dose radiation therapy for indolent non-Hodgkin lymphoma | Phase 2 | Scottsdale, Arizona and 6 other locations | Recruiting | Apr 26, 2024 |
| Combination treatment for indolent B-cell non-Hodgkin lymphoma | Phase 1/2 | Atlanta, Georgia and 26 other locations | Recruiting | Jun 27, 2018 |
All recruiting trials (4)
-
Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310
This study is testing a new treatment called SynKIR-310 to see if it can help adults with relapsed or refractory B-cell lymphoma feel better.
-
Using Ga-68-CXCR4 PET/CT to improve detection of indolent B-cell lymphoma
This study is testing a new type of PET scan to see if it can better detect and monitor slow-growing B-cell lymphoma in patients compared to the current method.
-
Reduced dose radiation therapy for indolent non-Hodgkin lymphoma
This study is testing if a lower dose of radiation therapy can safely treat people with indolent non-Hodgkin lymphoma while causing fewer side effects.
-
Combination treatment for indolent B-cell non-Hodgkin lymphoma
This study is testing a new combination of treatments for people with indolent B-cell non-Hodgkin lymphoma that hasn't responded to previous therapies to see if it can help them.
Related topics
Quick answers
How many Indolent B-Cell Non-Hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (3 trials), Taiwan (1 trial), Brazil (1 trial), Germany (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.